rs3823763
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_198428.3(BBS9):c.1789+420A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.42 in 151,938 control chromosomes in the GnomAD database, including 13,558 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.42 ( 13558 hom., cov: 32)
Consequence
BBS9
NM_198428.3 intron
NM_198428.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.03
Publications
4 publications found
Genes affected
BBS9 (HGNC:30000): (Bardet-Biedl syndrome 9) This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2017]
BBS9 Gene-Disease associations (from GenCC):
- Bardet-Biedl syndrome 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS9 | NM_198428.3 | c.1789+420A>C | intron_variant | Intron 17 of 22 | ENST00000242067.11 | NP_940820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.420 AC: 63706AN: 151820Hom.: 13547 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
63706
AN:
151820
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.420 AC: 63771AN: 151938Hom.: 13558 Cov.: 32 AF XY: 0.418 AC XY: 31039AN XY: 74246 show subpopulations
GnomAD4 genome
AF:
AC:
63771
AN:
151938
Hom.:
Cov.:
32
AF XY:
AC XY:
31039
AN XY:
74246
show subpopulations
African (AFR)
AF:
AC:
16877
AN:
41464
American (AMR)
AF:
AC:
5810
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1186
AN:
3464
East Asian (EAS)
AF:
AC:
2414
AN:
5156
South Asian (SAS)
AF:
AC:
1863
AN:
4826
European-Finnish (FIN)
AF:
AC:
4761
AN:
10538
Middle Eastern (MID)
AF:
AC:
106
AN:
292
European-Non Finnish (NFE)
AF:
AC:
29521
AN:
67906
Other (OTH)
AF:
AC:
827
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1884
3769
5653
7538
9422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1505
AN:
3470
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.